In focus · trending topic

afamelanotide

2 stories · following the connections

CLINUVEL reaches agreement on German SCENESSE® pricing through AMNOG Arbitration Board

By Nasdaq OMXApr 12, 2017, 9:10 AM UTC

FDA, CLINUVEL to Discuss SCENESSE® at Pre-NDA Meeting

By Nasdaq OMXOct 13, 2016, 11:01 AM UTC